IP Library Granted Patent US 10,912,635
Granted Patent B2
US 10,912,635 · App. 16/253,208 · Granted Feb 9, 2021

Systems and methods for treating a pelvic disorder

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,912,635
App. No.
16/253,208
Granted
Feb 9, 2021
Kind
B2
Abstract

Surgical instruments for pelvic repair can include straight portions and helical portions. Surgical methods for treating prolapse and other pelvic disorders can include passing a distal end region of the surgical instruments through pelvic tissue, associating an implant with the surgical instruments, and securing the implant in place to stabilize the vagina.

Claims (34)

1. A surgical method for treating a pelvic disorder in a patient, comprising:

providing a first surgical instrument and a second surgical instrument, the first and second surgical instruments including a needle portion, the needle portion of the first and second surgical instruments having a generally straight portion and a helical portion having a distal end region, wherein the generally straight portion of at least one of the first and second instruments has a longitudinal axis and the helical portion has an axis that is not parallel to the longitudinal axis of the straight portion;

providing an implant;

creating an incision;

passing the distal end region of the first surgical instrument through the incision;

associating the implant with the first surgical instrument;

associating the implant with the second surgical instrument; and

securing the implant in place to stabilize at least a portion of a vagina.

2. The method of claim 1 , wherein creating the incision includes creating a vaginal incision.

3. The method of claim 2 , wherein the vaginal incision is at a region of an apex of the vagina.

4. The method of claim 1 , wherein providing the first and second surgical instruments includes providing at least one of the first and second surgical instruments adapted for right-handed use.

5. The method of claim 1 , wherein providing the first and second surgical instruments includes providing at least one of the first and second surgical instruments adapted for left-handed use.

6. The method of claim 1 , further including fixating the implant to the vagina.

7. The method of claim 1 , wherein providing the implant includes providing a mesh implant.

8. The method of claim 7 , wherein providing the mesh implant includes providing the mesh implant constructed at least in part of an absorbable material.

9. The method of claim 7 , wherein providing the mesh implant includes providing the mesh implant having a separable sleeve.

10. The method of claim 9 , wherein the implant includes at least one dilating end portion.

11. The method of claim 10 , wherein the at least one dilating end portion includes opposing dilating end portions.

12. The method of claim 1 , wherein passing the distal end region of the first surgical instrument through the incision further includes passing the first surgical instrument through an inferior part of an obturator foramen.

13. A surgical method for treating a pelvic disorder in a patient, comprising:

providing a first surgical instrument including a first needle portion, the first needle portion having a straight portion and a helical portion having a first distal end region, wherein the straight portion of the first instrument has a longitudinal axis and the helical portion has an axis that is not parallel to the longitudinal axis of the straight portion;

providing a second surgical instrument including a second needle portion, the second needle portion having a second distal end region;

providing an implant having one or more dilating ends;

passing the first distal end region through an incision on a first side of the patient;

associating the implant with the first surgical instrument;

associating the implant with the second surgical instrument; and

placing the implant to stabilize pelvic tissue.

14. The method of claim 13 , wherein the incision is a vaginal incision.

15. The method of claim 14 , wherein the vaginal incision is at a region of an apex of the vagina.

16. The method of claim 13 , wherein providing the first and second surgical instruments includes providing at least one of the first and second surgical instruments adapted for right-handed or left-handed use.

17. The method of claim 13 , further including fixating the implant to the vagina.

18. The method of claim 13 , wherein providing the implant includes providing a mesh implant.

19. The method of claim 13 , wherein the implant includes a separable sleeve.

20. The method of claim 13 , wherein the one or more dilating end includes opposing dilating ends.

Assignments (12)
SECURITY INTEREST Recorded Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0682 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2024
From: ASTORA WOMEN’S HEALTH, LLC
To: ENDO USA, INC.
Reel/Frame 067202/0768 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2020
From: MELLIER, GEORGES
To: AMS RESEARCH CORPORATION
Reel/Frame 053869/0537 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2020
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 053870/0001 →
CHANGE OF NAME Recorded Sep 24, 2020
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 053870/0224 →
CHANGE OF NAME Recorded Sep 24, 2020
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 053886/0119 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded May 26, 2020
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 052752/0269 →